Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0BM3R
|
|||
Former ID |
DIB014821
|
|||
Drug Name |
LY-307853
|
|||
Synonyms |
LY307853; N-(1,4,7,13,16,22-Hexaaza-3,15-bis(hydroxyethyl)-6-(1,2-dihydroxy-2-(4-(phosphonooxy)phenyl)ethyl)-11,20,21,25-tetrahydroxy-26-methyl-2,5,8,14,17,23-hexaoxotricyclo[22.3.0.0<9,13>]heptacos-18-yl)(4-(4-(4-pentyloxyphenyl)phenyl)phenyl)formamide, sodium salt; [4-[(1S,2S)-1,2-dihydroxy-2-[tetrahydroxy-bis[(1R)-1-hydroxyethyl]-methyl-hexaoxo-[[4-[4-(4-pentoxyphenyl)phenyl]benzoyl]amino][ ]yl]ethyl]phenyl] dihydrogen phosphate
Click to Show/Hide
|
|||
Indication | Fungal infection [ICD-11: 1F29-1F2F; ICD-10: B35-B49; ICD-9: 110-118] | Terminated | [1] | |
Company |
Eli Lilly & Co
|
|||
Structure |
Download2D MOL
|
|||
Formula |
C58H73N7NaO19P
|
|||
Canonical SMILES |
CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(N=C4[O-])C(C)O)O)C(C(C7=CC=C(C=C7)[P+](O)(O)[O-])O)O)C(C)O)C)O)O)O.[Na+]
|
|||
InChI |
1S/C58H74N7O19P.Na/c1-5-6-7-24-84-39-20-16-35(17-21-39)33-10-8-32(9-11-33)34-12-14-37(15-13-34)51(73)59-41-26-43(69)54(76)63-56(78)47-48(70)29(2)27-65(47)58(80)45(31(4)67)61-55(77)46(50(72)49(71)36-18-22-40(23-19-36)85(81,82)83)62-53(75)42-25-38(68)28-64(42)57(79)44(30(3)66)60-52(41)74;/h8-23,29-31,38,41-50,54,66-72,76H,5-7,24-28H2,1-4H3,(H,59,73)(H,60,74)(H,61,77)(H,62,75)(H,63,78)(H2,81,82,83);/q;+1/p-1/t29-,30+,31+,38+,41+,42-,43+,44-,45-,46-,47-,48-,49-,50-,54+;/m0./s1
|
|||
InChIKey |
AMJZIRXAMIVVNS-PWPJTPCMSA-M
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008534) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.